CN108186799A - Ground bone slender acanthopanax dissipates and preparation method - Google Patents
Ground bone slender acanthopanax dissipates and preparation method Download PDFInfo
- Publication number
- CN108186799A CN108186799A CN201810099879.8A CN201810099879A CN108186799A CN 108186799 A CN108186799 A CN 108186799A CN 201810099879 A CN201810099879 A CN 201810099879A CN 108186799 A CN108186799 A CN 108186799A
- Authority
- CN
- China
- Prior art keywords
- parts
- skin
- chinese medicine
- dissipates
- nettle rash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 208000024780 Urticaria Diseases 0.000 claims abstract description 45
- 239000003814 drug Substances 0.000 claims abstract description 37
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 12
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 12
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 11
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 11
- 241001251949 Xanthium sibiricum Species 0.000 claims abstract description 11
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- 244000241872 Lycium chinense Species 0.000 claims abstract description 9
- 244000046095 Psophocarpus tetragonolobus Species 0.000 claims abstract description 9
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 206010030113 Oedema Diseases 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 5
- 230000004308 accommodation Effects 0.000 claims description 4
- 208000017520 skin disease Diseases 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 claims description 2
- 206010048768 Dermatosis Diseases 0.000 claims description 2
- 230000036783 anaphylactic response Effects 0.000 claims description 2
- 208000003455 anaphylaxis Diseases 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 23
- 230000000694 effects Effects 0.000 description 12
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 12
- -1 Alcohol ester Chemical class 0.000 description 9
- 229930182478 glucoside Natural products 0.000 description 9
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 8
- 150000008131 glucosides Chemical class 0.000 description 8
- 229930182470 glycoside Natural products 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 206010052568 Urticaria chronic Diseases 0.000 description 6
- 208000024376 chronic urticaria Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 6
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 6
- 230000010415 tropism Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- SNGHLUWTFLYPMT-JPRNBFAHSA-N (4as,8ar,8br,9as,12r,12as,14ar,14br)-12-(furan-3-yl)-7-hydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3h-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6h,9ah)-trione Chemical compound C=1([C@H]2[C@]3(C)CC[C@@H]4[C@@]56COC(=O)C[C@@H]5OC(C6=C(O)C(=O)[C@@]4(C)[C@]33O[C@@H]3C(=O)O2)(C)C)C=COC=1 SNGHLUWTFLYPMT-JPRNBFAHSA-N 0.000 description 4
- JODRRPJMQDFCBJ-UHFFFAOYSA-N 2-Hydroxy-4-methylbenzaldehyde Chemical compound CC1=CC=C(C=O)C(O)=C1 JODRRPJMQDFCBJ-UHFFFAOYSA-N 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- WIONIXOBNMDJFJ-UHFFFAOYSA-N Dictamnine Chemical compound C1=CC=C2C(OC)=C(C=CO3)C3=NC2=C1 WIONIXOBNMDJFJ-UHFFFAOYSA-N 0.000 description 4
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 210000003630 histaminocyte Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
- 229950005143 sitosterol Drugs 0.000 description 4
- 150000003432 sterols Chemical class 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 4
- 229940032091 stigmasterol Drugs 0.000 description 4
- 235000016831 stigmasterol Nutrition 0.000 description 4
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 4
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 4
- FIGVVZUWCLSUEI-UHFFFAOYSA-N tricosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCC FIGVVZUWCLSUEI-UHFFFAOYSA-N 0.000 description 4
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 3
- IRLNKOAURQPXIQ-WWWUCTDISA-N Apiopaeonoside Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]3[C@H](O)[C@@](O)(CO)CO3)O2)cc(OC)cc1 IRLNKOAURQPXIQ-WWWUCTDISA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WPNOWVWMZUYEQO-UHFFFAOYSA-N Fraxinellone Natural products CC1=C2C(=O)OC(c3occc3)C2(C)CCC1 WPNOWVWMZUYEQO-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 3
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 3
- TWGHMXOYRUTQOL-UHFFFAOYSA-N O-Methylconfusameline Natural products COC1=C2C=COC2=NC2=CC(OC)=CC=C21 TWGHMXOYRUTQOL-UHFFFAOYSA-N 0.000 description 3
- IDZZECHGWAZTIB-NYBIBFQCSA-N Paeonolide Chemical compound COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H](O)[C@@H](O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-NYBIBFQCSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 244000197580 Poria cocos Species 0.000 description 3
- 235000008599 Poria cocos Nutrition 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- SLSIBLKBHNKZTB-UHFFFAOYSA-N Skimmianine Chemical compound COC1=C2C=COC2=NC2=C(OC)C(OC)=CC=C21 SLSIBLKBHNKZTB-UHFFFAOYSA-N 0.000 description 3
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 3
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 3
- 235000000431 campesterol Nutrition 0.000 description 3
- 230000003098 cholesteric effect Effects 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- CFUCIRVWWMWUQN-UHFFFAOYSA-N gamma-Fagarine Natural products N1=C2C(OC)=CC=CC2=C(OC)C2=C1OCO2 CFUCIRVWWMWUQN-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 239000003018 immunosuppressive agent Substances 0.000 description 3
- DOMJKIVDRZSIJN-UHFFFAOYSA-N kokusaginine Natural products COC12Cc3ncccc3CC1(OC)C=CO2 DOMJKIVDRZSIJN-UHFFFAOYSA-N 0.000 description 3
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 3
- 229960003088 loratadine Drugs 0.000 description 3
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940044551 receptor antagonist Drugs 0.000 description 3
- 239000002464 receptor antagonist Substances 0.000 description 3
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 3
- SACPYSHBQFRBLR-UHFFFAOYSA-N skimmianine Natural products COC1=C2C=COC2Nc3c(OC)c(OC)ccc13 SACPYSHBQFRBLR-UHFFFAOYSA-N 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- CMJGAYUQSLJSCR-WACFDSSMSA-N (-)-Hibalactone Natural products C1=C2OCOC2=CC(/C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-WACFDSSMSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- XWGNIHFUPLLNBR-GZCFXPHUSA-N (1r,4s,6s,8ar)-1-(furan-3-yl)-4,6-dihydroxy-5,8a-dimethyl-4,6,7,8-tetrahydro-1h-isochromen-3-one Chemical compound C=1([C@@H]2OC(=O)[C@@H](O)C3=C([C@H](CC[C@]32C)O)C)C=COC=1 XWGNIHFUPLLNBR-GZCFXPHUSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- QJYNZEYHSMRWBK-NIKIMHBISA-N 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose Chemical compound OC1=C(O)C(O)=CC(C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 QJYNZEYHSMRWBK-NIKIMHBISA-N 0.000 description 2
- LNJTUUHDKCPQAA-UHFFFAOYSA-N 1-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-3-methylbut-3-en-2-ol Chemical compound N1=C2C(OC)=C(OCC(O)C(C)=C)C=CC2=C(OC)C2=C1OC=C2 LNJTUUHDKCPQAA-UHFFFAOYSA-N 0.000 description 2
- LCZUOKDVTBMCMX-UHFFFAOYSA-N 2,5-Dimethylpyrazine Chemical compound CC1=CN=C(C)C=N1 LCZUOKDVTBMCMX-UHFFFAOYSA-N 0.000 description 2
- OXCKCFJIKRGXMM-UHFFFAOYSA-N 2-ethyl-5-methylpyrazine Chemical compound CCC1=CN=C(C)C=N1 OXCKCFJIKRGXMM-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 2
- OAEZQCLAAGSHHA-UHFFFAOYSA-N 4,7,8-trimethoxy-3-(3-methylbut-2-enyl)-1h-quinolin-2-one Chemical compound COC1=C(CC=C(C)C)C(=O)NC2=C(OC)C(OC)=CC=C21 OAEZQCLAAGSHHA-UHFFFAOYSA-N 0.000 description 2
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 2
- FXHBKLQQNAGNJN-UHFFFAOYSA-N 6,8-dimethoxy-9-methylfuro[2,3-b]quinolin-4-one Chemical compound O=C1C2=CC(OC)=CC(OC)=C2N(C)C2=C1C=CO2 FXHBKLQQNAGNJN-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- XWGNIHFUPLLNBR-OPQSFPLASA-N Dictamdiol Natural products C=1([C@H]2OC(=O)[C@H](O)C3=C([C@@H](CC[C@@]32C)O)C)C=COC=1 XWGNIHFUPLLNBR-OPQSFPLASA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 102000003834 Histamine H1 Receptors Human genes 0.000 description 2
- 108090000110 Histamine H1 Receptors Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CMJGAYUQSLJSCR-UUASQNMZSA-N Isohabilactone Natural products C1=C2OCOC2=CC(/C=C2/C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UUASQNMZSA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 2
- 108010080154 N-benzoylphenylalanylphenylalinol acetate Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- IDZZECHGWAZTIB-WPQJODJHSA-N Paeonolide Natural products O=C(C)c1c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)CO3)O2)cc(OC)cc1 IDZZECHGWAZTIB-WPQJODJHSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- XVXPXUMUGATHPD-JMJRLLIOSA-N Simiarenol Chemical compound C([C@@H]1[C@@]2(C)CC[C@@]3(C)[C@H]([C@@]2(CC[C@]11C)C)CC[C@@H]3C(C)C)C=C2[C@H]1CC[C@H](O)C2(C)C XVXPXUMUGATHPD-JMJRLLIOSA-N 0.000 description 2
- XVXPXUMUGATHPD-UHFFFAOYSA-N Simiarol Natural products CC(C)C1CCC(C2(CCC34C)C)C1(C)CCC2(C)C3CC=C1C4CCC(O)C1(C)C XVXPXUMUGATHPD-UHFFFAOYSA-N 0.000 description 2
- PBWOIPCULUXTNY-UHFFFAOYSA-N Sitosterylacetat Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 PBWOIPCULUXTNY-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 2
- 229930192007 acanthoside Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- IDZZECHGWAZTIB-UHFFFAOYSA-N affinoside Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)=C1 IDZZECHGWAZTIB-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- VZPAURMDJZOGHU-SKCDSABHSA-N aurantiamide acetate Chemical compound C([C@@H](COC(=O)C)NC(=O)C(CC=1C=CC=CC=1)NC(=O)C=1C=CC=CC=1)C1=CC=CC=C1 VZPAURMDJZOGHU-SKCDSABHSA-N 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 2
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 206010009869 cold urticaria Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229930190029 eleutheroside Natural products 0.000 description 2
- 239000008769 eleutheroside Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- KFBCTNNQFGONHB-UHFFFAOYSA-N gamma-Fagarine Chemical compound N1=C2C(OC)=CC=CC2=C(OC)C2=C1OC=C2 KFBCTNNQFGONHB-UHFFFAOYSA-N 0.000 description 2
- HFSACQSILLSUII-ISSAZSKYSA-N glutinol Chemical compound C([C@@H]1[C@@]2(C)CC[C@@]3(C)CCC(C[C@H]3[C@]2(C)CC[C@]11C)(C)C)C=C2[C@H]1CC[C@H](O)C2(C)C HFSACQSILLSUII-ISSAZSKYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- CMJGAYUQSLJSCR-UHFFFAOYSA-N hibalactone Natural products C1=C2OCOC2=CC(C=C2C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 229960004469 methoxsalen Drugs 0.000 description 2
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 2
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 235000020995 raw meat Nutrition 0.000 description 2
- CMJGAYUQSLJSCR-ULIPXBITSA-N savinin Chemical compound C1=C2OCOC2=CC(\C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-ULIPXBITSA-N 0.000 description 2
- JGPMLTMSOKTANE-UHFFFAOYSA-N savinin Natural products O=C1OCC(/C/1=Cc2ccc3OCOc3c2)c4ccc5OCOc5c4 JGPMLTMSOKTANE-UHFFFAOYSA-N 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- IPEHJNRNYPOFII-AZUAARDMSA-N sugiol Chemical compound CC([C@@H]1CC2=O)(C)CCC[C@]1(C)C1=C2C=C(C(C)C)C(O)=C1 IPEHJNRNYPOFII-AZUAARDMSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- CZEPBGSMIRTHKN-UHFFFAOYSA-N (+-)-Kryptojaponol Natural products O=C1CC2C(C)(C)CCCC2(C)C2=C1C=C(C(C)C)C(OC)=C2O CZEPBGSMIRTHKN-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- VELYAQRXBJLJAK-XKKWFBPMSA-N (2s,3r,4s,5s,6r)-2-[[(1s,4ar,5r,7s,7as)-5,7-dihydroxy-7-methyl-4a,5,6,7a-tetrahydro-1h-cyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O([C@@H]1OC=C[C@H]2[C@H](O)C[C@@]([C@@H]12)(O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-XKKWFBPMSA-N 0.000 description 1
- IZVFFXVYBHFIHY-UHFFFAOYSA-N (3alpha, 5alpha)-Cholest-7-en-3-ol, 9CI Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CCC21 IZVFFXVYBHFIHY-UHFFFAOYSA-N 0.000 description 1
- CZEPBGSMIRTHKN-KKSFZXQISA-N (4as,10as)-5-hydroxy-6-methoxy-1,1,4a-trimethyl-7-propan-2-yl-3,4,10,10a-tetrahydro-2h-phenanthren-9-one Chemical compound CC([C@@H]1CC2=O)(C)CCC[C@]1(C)C1=C2C=C(C(C)C)C(OC)=C1O CZEPBGSMIRTHKN-KKSFZXQISA-N 0.000 description 1
- SKIOPIHJJBPUOQ-XQWCSVHFSA-N (6R)-6-[(9R,10S,13R,14R,17R)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-3-ethyl-2-methylheptan-1-ol Chemical compound C(C)C(C(CO)C)CC[C@@H](C)[C@H]1CC[C@H]2C3=CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C SKIOPIHJJBPUOQ-XQWCSVHFSA-N 0.000 description 1
- VZRAKVPDZIQRGT-WZBAXQLOSA-N (8r,9s,10s,13r,14s,17r)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C=C)[C@@H]4[C@@H]3CCC21 VZRAKVPDZIQRGT-WZBAXQLOSA-N 0.000 description 1
- 229920002793 1,2,3,4,6-Pentagalloyl glucose Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XJSSRXITQUJZLO-UHFFFAOYSA-N 16alpha-Hydroxy-kauran-19-saeure Natural products C1CC2C3(C)CCCC(C)(C(O)=O)C3CCC22CC(C)(O)C1C2 XJSSRXITQUJZLO-UHFFFAOYSA-N 0.000 description 1
- 239000001934 2,5-dimethylpyrazine Substances 0.000 description 1
- HJFZAYHYIWGLNL-UHFFFAOYSA-N 2,6-Dimethylpyrazine Chemical class CC1=CN=CC(C)=N1 HJFZAYHYIWGLNL-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 1
- 239000001908 2-ethyl-5-methylpyrazine Substances 0.000 description 1
- NPJICTMALKLTFW-PYOHOBBFSA-N 3-O-beta-D-Glucopyranosyl sitosterol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 NPJICTMALKLTFW-PYOHOBBFSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical group Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- GKBHKNPLNHLYHT-OWDZWQNUSA-N 5alpha-stigmastane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 GKBHKNPLNHLYHT-OWDZWQNUSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- 244000167222 Acanthopanax sessiliflorus Species 0.000 description 1
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 description 1
- VELYAQRXBJLJAK-TYNWJONJSA-N Ajugol Natural products O([C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1OC=C[C@@H]2[C@H](O)C[C@@](O)(C)[C@@H]12 VELYAQRXBJLJAK-TYNWJONJSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241001674345 Callitropsis nootkatensis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- IPEHJNRNYPOFII-UHFFFAOYSA-N DL-Sugrol Natural products O=C1CC2C(C)(C)CCCC2(C)C2=C1C=C(C(C)C)C(O)=C2 IPEHJNRNYPOFII-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FIZZAWTVIDYQPI-UHFFFAOYSA-N Dictamnol Natural products C1=CCCC(=C)C2C1C(C)(O)CC2 FIZZAWTVIDYQPI-UHFFFAOYSA-N 0.000 description 1
- 241001299817 Dictamnus Species 0.000 description 1
- 244000182625 Dictamnus albus Species 0.000 description 1
- 241000219764 Dolichos Species 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000092728 Eleutherococcus gracilistylus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001625909 Eremurus chinensis Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- XYYAFLHHHZVPRN-GXTWGEPZSA-N Fraxinellone Chemical compound C=1([C@@H]2OC(=O)C3=C(CCC[C@]32C)C)C=COC=1 XYYAFLHHHZVPRN-GXTWGEPZSA-N 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- RBANQYSPMJFZBG-UHFFFAOYSA-N Glut-5-en-3beta-ol Natural products CC1(C)CCC2(C)CCC3(C)C4CC=C5C(CCC(O)C5(C)C)C4CCC3(C)C2C1 RBANQYSPMJFZBG-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- OUGPMNMLWKSBRI-UHFFFAOYSA-N Hexyl formate Chemical compound CCCCCCOC=O OUGPMNMLWKSBRI-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- IQPSCJJRYFMIOC-VVFZLFBHSA-N Isomultiflorenyl acetate Chemical compound C([C@H]1[C@]2(C)CC3)C(C)(C)CC[C@]1(C)CC[C@]2(C)C1=C3[C@@]2(C)CC[C@H](OC(=O)C)C(C)(C)C2CC1 IQPSCJJRYFMIOC-VVFZLFBHSA-N 0.000 description 1
- IQPSCJJRYFMIOC-UHFFFAOYSA-N Isomultifluorenyl-acetat Natural products C1CC2(C)C3CC(C)(C)CCC3(C)CCC2(C)C2=C1C1(C)CCC(OC(=O)C)C(C)(C)C1CC2 IQPSCJJRYFMIOC-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 229930183024 Kukoamine Natural products 0.000 description 1
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010068773 Mechanical urticaria Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- SMZJVUVNROXPST-UHFFFAOYSA-N O-Ethylnordictamnin Natural products C1=CC=C2C(OCC)=C(C=CO3)C3=NC2=C1 SMZJVUVNROXPST-UHFFFAOYSA-N 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- AVIUTYMRHHBXPB-UXXRCYHCSA-N Paeonoside Natural products COC1=CC=C(C(C)=O)C(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 AVIUTYMRHHBXPB-UXXRCYHCSA-N 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- YZMKFMIZNSOPSN-XGTMLCIVSA-N Rutaevin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)[C@@H](O)C(=O)[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 YZMKFMIZNSOPSN-XGTMLCIVSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 206010046742 Urticaria contact Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- PWACSDKDOHSSQD-IUTFFREVSA-N acrivastine Chemical compound C1=CC(C)=CC=C1C(\C=1N=C(\C=C\C(O)=O)C=CC=1)=C/CN1CCCC1 PWACSDKDOHSSQD-IUTFFREVSA-N 0.000 description 1
- 229960003792 acrivastine Drugs 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- NPDSHTNEKLQQIJ-KPWHUNMNSA-N alpha-dimorphecolic acid Natural products CCCCCC=C\C=C\C(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-KPWHUNMNSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000008624 aquagenic urticaria Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229960004574 azelastine Drugs 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 229950002342 bisfentidine Drugs 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 201000000409 dermatographia Diseases 0.000 description 1
- NFDFQCUYFHCNBW-SCGPFSFSSA-N dienestrol Chemical compound C=1C=C(O)C=CC=1\C(=C/C)\C(=C\C)\C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-SCGPFSFSSA-N 0.000 description 1
- SMSBSJNIBCNVES-UHFFFAOYSA-N dihydro-evoxoidine Natural products COc1c2ccoc2nc3c(OC)c(OCC(O)C(C)C)ccc13 SMSBSJNIBCNVES-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
- 229960001971 ebastine Drugs 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- FWTBRZMBHIYQSW-UHFFFAOYSA-N epifriedelanol Natural products CC1C(O)C(O)CC2C1(C)CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)C(O)CC34C FWTBRZMBHIYQSW-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000020157 familial dermatographia Diseases 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- AVIUTYMRHHBXPB-UHFFFAOYSA-N glucopaeonol Natural products COC1=CC=C(C(C)=O)C(OC2C(C(O)C(O)C(CO)O2)O)=C1 AVIUTYMRHHBXPB-UHFFFAOYSA-N 0.000 description 1
- OLWSWWUSGLHFEB-UHFFFAOYSA-N glutinol Natural products CC1C(O)CCC2C1=CCC3C2(C)CCC4(C)C5CC(C)(C)CCC5(C)CCC34C OLWSWWUSGLHFEB-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940073062 imuran Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- XFFQVRFGLSBFON-DEFKTLOSSA-N kaempferol 3,7-di-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=C(C=3C=CC(O)=CC=3)OC2=C1 XFFQVRFGLSBFON-DEFKTLOSSA-N 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- MKDZWZUILDTUBG-GARJFASQSA-N lyciumin Natural products Oc1ccc(cc1)[C@H]2OC[C@H]3[C@@H]2COC3=O MKDZWZUILDTUBG-GARJFASQSA-N 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- VELYAQRXBJLJAK-UHFFFAOYSA-N myoporoside Natural products C12C(C)(O)CC(O)C2C=COC1OC1OC(CO)C(O)C(O)C1O VELYAQRXBJLJAK-UHFFFAOYSA-N 0.000 description 1
- FXJAOWANXXJWGJ-UHFFFAOYSA-N n-[4-(2-methyl-1h-imidazol-5-yl)phenyl]-n'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=C(C)N1 FXJAOWANXXJWGJ-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000012165 plant wax Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- KYJFVUCTTPMUHL-UHFFFAOYSA-N preskimmianine Natural products CC(=CCC1=C(C)c2ccc(C)c(C)c2NC1=O)C KYJFVUCTTPMUHL-UHFFFAOYSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000010499 rapseed oil Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- YNJNXTVCNRVZJI-UHFFFAOYSA-N rutaevin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(OC(=O)C6OC56C4(C)C(O)C(=O)C13)c7occc7 YNJNXTVCNRVZJI-UHFFFAOYSA-N 0.000 description 1
- YZMKFMIZNSOPSN-UHFFFAOYSA-N rutaevine Natural products CC1(C)OC2CC(=O)OCC22C1C(=O)C(O)C(C13OC1C(=O)O1)(C)C2CCC3(C)C1C=1C=COC=1 YZMKFMIZNSOPSN-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- PCZXEAAHGUQDNV-XBNKRBCZSA-N tetrahymanol Natural products CC1(C)CC[C@]2(C)CC[C@]3(C)[C@H]4CC[C@H]5[C@@H](CC[C@H](O)C5(C)C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1 PCZXEAAHGUQDNV-XBNKRBCZSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- NZHGWWWHIYHZNX-CSKARUKUSA-N tranilast Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-CSKARUKUSA-N 0.000 description 1
- 229960005342 tranilast Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- OLTHARGIAFTREU-UHFFFAOYSA-N triacontane Natural products CCCCCCCCCCCCCCCCCCCCC(C)CCCCCCCC OLTHARGIAFTREU-UHFFFAOYSA-N 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- SUJUOAZFECLBOA-UHFFFAOYSA-N tritriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC SUJUOAZFECLBOA-UHFFFAOYSA-N 0.000 description 1
- 239000012873 virucide Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ground bone slender acanthopanax the present invention relates to a kind of pure Chinese medicine treatment nettle rash dissipates and preparation method, is prepared by following Chinese medicine material:10-20 parts of the root bark of Chinese wolf-berry, 15-35 parts of cortex acanthopanacis, 15-25 parts of dittany bark, 10-15 parts of dry Radix Rehmanniae, 5-10 parts of unpeeled CORTEX MOUTAN, 15-35 parts of fuling peel, white 15-25 parts of Siberian cocklebur skin, 15-20 parts of waxgourd peel, 15-25 parts of hyacinth bean skin.It is an advantage of the current invention that used Chinese medicine meets Pharmacopoeia of People's Republic of China regulation, medicine materials safety is reliable;The method have the characteristics that the reasonable compatibility of drug, is with organic conception, dialectical treatmert, the theory of traditional Chinese medical science searched for the primary cause of disease in treatment is guidance.
Description
Technical field
The present invention relates to a kind of pure Chinese medicine compatibility oral powders;More particularly to a kind of ground bone five of pure Chinese medicine treatment nettle rash
Add scattered and preparation method.
Background technology
Nettle rash is commonly called as wheal.It is due to a kind of office that skin, the expansion of mucous membrane thin vessels and permeability increase and occur
Sex-limited oedema reaction, repeated, several years protracted course a few days to months, be common clinical frequently-occurring disease.The cause of disease of nettle rash
Extremely complex, about 3/4 patient can not find reason, particularly chronic urticaria.Common cause mainly has:Food and food addition
Agent;Inhalation (inhalatio);Infection;Drug;Physical factor such as mechanical stimulus, cold and hot, daylight etc.;Insect bites;Mental element and endocrine
Change;Inherent cause etc..
Clinical manifestation;There is wheal for skin in basic lesions.Often first there is pruitus, occur wheal immediately, in cerise
Or pale asphyxia, skin-color, small number of patients have edematous erythema.The size and form of wheal differ, and duration of seizure is indefinite.Wheal by
It gradually spreads, fusion is in blocks, due to papilla oedema, it is seen that epidermis follicular orifice is to lower recess.Wheal last for several minutes is to several small
When, minority subsides after can extending to a couple of days, leaves no trace.Fash occurs in batch repeatedly, common to send out author at dusk.Wheal is often general
Hair, can also limit to.Sometimes merge angioedema, wheal surface forms bleb once in a while.Some patientss can with Nausea and vomiting,
Headache, alliteration, abdominal pain, diarrhea, severe patient can also have that uncomfortable in chest, uncomfortable, pale complexion, heart rate accelerates, pulse is thin and delicate, under blood pressure
The constitutional symptoms such as drop, short of breath.
Nettle rash is divided into as acute urticaria, chronic urticaria plain edition nettle rash, the nettle of also following specific type
Rash.1. dermatograph nettle rash/dermatographism;2. retardance dermographism;3. retardance pressure nettle rash;4. choline
It can property nettle rash;5. cold urticaria;6. urticaria solaris;7. contact urticaria;In addition, also thermal urticaria, fortune
Dynamic property nettle rash, trembling property nettle rash, aquagenic urticaria, adrenergic nettle rash, galvanic nettle rash etc. are more rare
The nettle rash of type etc..
Existing therapy:1. general treatment, different due to nettle rash, therapeutic effect is also different.(1)Removal disease
Cause(2)Avoid risk factor.
Western medicine:(1)1. H receptor antagonists have stronger antihistamine and resist other inflammatory mediators Loratadine
Effect, treating various nettle rash, effective long-term effect is undesirable in short term.Common H1 receptor antagonists have diphenhydramine, match
Pyridine in heptan, chlorpheniramine etc., Acrivastine, cetirizine, imidazoles this fourth, Loratadine, Ebastine, azelastine, chlorine thunder he
It is fixed etc.;Can select two distinct types of H1 receptor antagonists share or with bisfentidine use in conjunction, common H2
Receptor antagonist has Cimetidine, ranitidine, famotidine etc..For acute and chronic nettle rash and cold urticaria;It is 2. more
It is a kind of tricyclic antidepressants that plug is flat, for chronic urticaria;(2)Inhibit mast cell degranulation, reduce histamine and release
The drug put:1. sulfuric acid terbutaline is 2 adrenoreceptor accelerating agents of β, the concentration of cAMP can be increased in vivo, from
And inhibit mast cell degranulation;2. ketotifen inhibits mast cell degranulation, prevents scorching by increasing the concentration of internal cAMP
Disease medium(Such as histamine, slow reacting substance)Release;3. nasmil can block the combination of antigen-antibody, inhibit inflammatory mediator
Release;4. tranilast reduces the release of histamine by stablizing mast cell membrane;In addition, reduce the medicine of vasopermeability
Object, such as vitamin C, citrin, calcium agent, often share with glucocorticoid, antihistamine.(4)Immunosuppressor:When chronic
Nettle rash patient has autoimmunity basis, and Relapse rate can apply immunosuppressor, cyclosporine, imuran, ring phosphinylidyne
Amine, methotrexate (MTX) and immunoglobulin, tripterygium wilfordii etc. can be tried out, since the rate of side effects of immunosuppressor is high, generally
The treatment for nettle rash is not recommended.
Above all prescriptions, acute to urticaria, short-term effective, long-term effect is uneven preferable, some chronic patients state of an illness are anti-
As long as plural year many decades, protracted course of disease.
Invention content
According to more than the deficiencies in the prior art, the present invention provides a kind of ground bone slender acanthopanax of pure Chinese medicine treatment nettle rash and dissipates and make
Preparation Method reaches more preferable curative effect, in parts by weight and compatibility, is prepared by following Chinese medicine material, which is characterized in that step is such as
Under:10-20 parts of the root bark of Chinese wolf-berry, 15-35 parts of cortex acanthopanacis, 15-25 parts of dittany bark, 10-15 parts of dry Radix Rehmanniae, 5-10 parts of unpeeled CORTEX MOUTAN,
15-35 parts of fuling peel, white 15-25 parts of Siberian cocklebur skin, 15-20 parts of waxgourd peel, 15-25 parts of hyacinth bean skin.
A kind of ground bone slender acanthopanax of pure Chinese medicine treatment nettle rash dissipates and preparation method, which is characterized in that step is as follows:Ground bone
Skin, cortex acanthopanacis, dittany bark, dry Radix Rehmanniae, unpeeled CORTEX MOUTAN, fuling peel, Bai Lingpi dry removal impurity, weigh spare.By more than frying
Good spare spice, weighs backup, and crushing and processing are stirred evenly, filtering 200 mesh packing into smalls, and often packet is packed as 120 grams,
It encapsulates spare.
Usage and dosage:Three times per day, one time one packet(120 grams), boiling water is taken after being infused in hot water or decoction or is decocted in water for oral dose, 15 days as one therapeutic course.
Accommodation;A variety of anxious, slow nettle rash, anaphylaxis dermatosis, oedema dermatoses, constipation etc..
It is an advantage of the current invention that used Chinese medicine meets Pharmacopoeia of People's Republic of China regulation, medicine materials safety
Reliably, from natural traditional Chinese medicine;The method have the characteristics that the reasonable compatibility of drug, is with organic conception, dialectical treatmert is cured the disease
This theory of traditional Chinese medical science is sought as guidance.
Pharmacological action
Hyacinth bean skin:English name Seed-coat of Hyacinth Dolichos.Kind skin for legume hyacinth bean.Pharmacological property:It is sweet
It is bitter;Temperature;Channel tropism:Spleen;Large intestine channel;Effect:It relieves summer heat dampness elimination, strengthening the spleen and stomach;It cures mainly:Accumulate in summer-heat and damp, vomiting and diarrhea, it is uncomfortable in chest indigestion and loss of appetite,
Beriberi edema, women is under;Usage and dosage takes orally:Decoction, 3-9g.1.《Book on Chinese herbal medicine is just read》:Up to flesh row water.2.《Anhui medicinal material》:
Tonifying spleen dampness elimination, antidiarrheal dysentery.It controls food poisoning property to suffer from vomiting and diarrhoea, solves alcoholism.3.《Plant medicine will in Jiangsu》:It is swollen enough to control tinea pedis.
Waxgourd peel:English name Chinese Waxgourd Peel, Peel of Chinese Waxgourd.For Curcurbitaceae
The outside rind of plant wax gourd.Pharmacological property:It is sweet in flavor;Cold nature;Channel tropism:Return lung;Spleen;Small intestinl channel;Effect:Clearing away heat and promoting diuresis;Detumescence;It is main
It controls;Oedema;Difficult urination;Diarrhea;Sore swells;Usage and dosage:It is for oral administration:Decoction, 15-30g.External application:In right amount, washing is decocted.Chinese medicine
It studies point:Waxgourd peel contains volatile ingredient:E-2- olefine aldehydrs(E-2-hexe-nal), just olefine aldehydr(N-hexenal), formic acid is being just
Alcohol ester(N-hexyl formate), 2,5- dimethyl pyrazines(2,5-dimethylpyra-zine), 2,6- dimethyl pyrazines
(2-ethyl-5-methylpyrazine)[1].Contain triterpene compound again:It is sour different to spend more Eremurus chinensis enol ester
(Isomultiflorenyl acetate) [2], glut-5-en-3β-ol(Glutinol), simiarenol(Simiarenol), 5,24-
Cucurbit dienol(cucurbita-5,24-dienol)[3];Cholesterin derivative:24- this cholesteric -7,25- dienols(24-
Ethylcholesta-7,25-dienol), 24- base cholesterics -7,22, tri- enols of 25-(24-ethylcholesta-7,22,
25-trienol), 24- this cholest-7-enol(24-ethylcholesta-7-enol), 24- base cholesteric -7,22- diene
Alcohol(24-ethylchol-lesta-7,22-dienol)[4].Separately contain vitamin(Vitamin) B1, B2, C, niacin
(Niacin), carrotene(Carotene), glucose(Glucose), fructose(Fructose), sucrose(Srcrose), it is organic
The inorganic elements such as acid, starch and sodium, potassium, calcium, iron, manganese, zinc.
Fuling peel:English name:Indian Bread peel, Tuckahoe peel.For On Polyporaceae poria cocos sclerotium
Crust.Pharmacological property:It is sweet;It is light;It is mild-natured;Channel tropism:Kidney;Bladder warp;Effect:Inducing diuresis for removing edema;It cures mainly:Water temperature turgor;Difficult urination;With
Method dosage:It is for oral administration:Decoction, 3-5g.1.《Detailed outline》:Main oedema general edema, channell, loosing the interspaces of skin and muscles.2.《Medical center bun will》:Row skin it
Water.
Unpeeled CORTEX MOUTAN:English name:Tree Peony Bark.Root skin for Paeoniaceae plant tree peony.Pharmacological property:It is arduous;It is cool;It is micro-
It is cold;Channel tropism:The heart;Liver;Kidney;Lung channel;Effect:Heat-clearing;Promoting blood circulation to remove blood stasis;It cures mainly:Warm heat disease heat invading xuefen;Send out spot;Hematemesis;Hot tears are full of
Socket of the eye germ later stage hot Fu Yin distributions heat;Deficiency of Yin osteopyrexia and fever;Amenorrhea due to stagnation of blood;Dysmenorrhoea;Carbuncle sore tumefacting virus;The pain of injury caused by falling and tumbling;Beriberoid pyretic arthralgia,
Usage and dosage:It is for oral administration:Decoction, 6-9g;Or enter ball, dissipate.Chemical composition of Chinese materia medica:Root skin contains Paeoniflorin(Paeonifolrin), oxygen
Change Paeoniflorin(Oxypaeoniflorin), benzoylpaeoniflorin(Benzoylpaeoniflorin), paeonol(Paeonol),
Paeonolide(Paeonoside), paeonolide(Paeonollide), paeonol Neogroside(Apiopaeonoside), benzene first
Acyl group oxidized paeoniflorin glycosides(Benxoyloxy-paeoniflorin), 2,3- dihydroxy -4- methoxyacetophenones(2,3-
Dihydroy-4-methoxyacetophenone), 3- hydroxyls -4- methoxyacetophenones(3-hydroxy-4-
Methoxyacetophenone), 1,2,3,4,6- five galloyl glucoses(1,2,3,4,6-
Pentagalloylglucose) gallic acid(Gallic acid) etc..
Dittany bark:English name:Densefruit Pittany Root-bark, Root-bark of Densefruit
Pittany;Pharmacological property:It is bitter;It is salty;It is cold;Channel tropism:Spleen;Lung;Small intestine;Stomach;Bladder warp, effect:Heat-clearing and damp-drying drug;Dispelling wind and arresting itching;Removing toxic substances,
It cures mainly:Rubella caused by wind-heat wet poison;Eczema;Mange;Jaundice;Damp-heat arthralgia;Usage and dosage:It is for oral administration:Decoction, 6-15g;Or enter
Ball dissipates.External application:In right amount, it decocts washing or grinds deposited.Medication is avoided:Asthenia cold syndrome avoids clothes.Chemical composition of Chinese materia medica:1. shaggy-fruited dittany overground part
Divide containing psoralen(Psoralen), xanthotoxin(Xanthotoxin), Scopoletin(Scopoletin), Quercetin
(Quercetin), isoquercitin(Isoquercetin), root contains dictamine(Dictamnine), γ-fagarine(γ-
Fagarine), preceding skimmianine(Preskimmianine) ], skimmianine(Skimmia-_nine), dasycarpamin
(Dasycarpamin), trigonelline(Trigonelline), choline(Choline), O- ethyls-drop-dictamine(O-
Ethylnordictamnine), O- ethyls-drop-γ-fagarine(O-ethylnor- γ-fagarine),
Www.med126.comO- ethyls-drop-skimmianine(O-ethylnorskimmianine), different spot boiling woods potash
(Isomaculosidine), evodine(Rutaevin), shaggy-fruited dittany alcohol(Dictamnol), pregnene acid ketone
(Peregnenolone), fraxinellon(Fraxinellone), obakunone(Obacunone), limonin(Limonin), β-paddy
Sterol(β-sitosterol), Lay oil sterol(Campesterol), saponin etc..2. contain fraxinellon in Dictamnus angustifolius root skin, it is yellow
Cypress ketone, limonin, limonin diosphenol() and Dictamdiol limonindiosphenol(dictamdiol).
The root bark of Chinese wolf-berry:It is the root skin of matrimony vine Lycium chinense Mill. for Solanaceae, Lycium.It is sweet in flavor;It is cold in nature;
Return lung;Kidney channel;Effect:Clearind deficient heat;Purte the white;Cool blood.It cures mainly:Hectic fever due to yin deficiency;Hectic fever due to yin night sweat;Infantile malnutrition generates heat;Lung heat is breathed heavily
Cough;It spits blood;Bleeding from five sense organs or subcutaneous tissue;Hematuria;It quenches one's thirst;Usage and dosage:It is for oral administration:Decoction, 9-15g;Large dosage can use 15-30g.Chemistry for Chinese Traditional Medicine into
Point:Lycii radicis,cortex contains alkaloid:Glycine betaine(Betaine) [1], hardship can amine(Kukoamine) A [2] and for immunological regulation,
The 1 of agent, virucide, tumor inhibitor etc., 2,3,4,7,-penta hydroxy group -6- azabicyclos [3.3.0] octane(1,2,3,4,7-
Pen-tahydroxy-6nitro-bicycol [3,3,0]-octane) and Isosorbide-5-Nitrae, 7,8- tetrahydroxy -6- azabicyclos [3,3,0]
Octane(Isosorbide-5-Nitrae, 7,8-tetrahydroxy-6-nitrobicycol [3,3,0]-octane) [3].It acts on and resists containing anti-feritin again
The matrimony vine ring octapeptide of angiotensinⅠ converting enzyme active function(Lyciumin) A and B [4,5].The also antiangiotensin I containing tool
The organic acid of converting enzyme active function:(S) -9- hydroxyls -10E, 12Z- octadecadienoic acid [(S) -9-hydroxy-10E, 12Z-
Octadecadienoic acid] and(S) 9- hydroxyls 10E, 12Z, 15Z- octatecatrienoic acids [(S)-9-hydroxy-10E,
12Z,15Z-octadecatrienoic acid][6].Still contain lyciumamide(Lyciumamide) it is the orange piperyl of acetic acid
Amine ester(Aurantiamideacetae) [7], linoleic acid(linoleic acid)[1].Leukotrienes(Linollenic acid),
Melissic acid(Melissic acid), cinnamic acid(Cinnamic acid), cryptojaponol(Sugiol), 5 α-stigmastane -3,6- diketone
(5 α-stig-mastane-3,6-dine) [8], Scopoletin(Scopoletin) [6], cupreol glycoside(β-
Sitosterol glucoside) [9], Scopoletin(Scopoletin) [6], cupreol glycoside(β-sitoserol
Glucosde) [9] etc..Root contains with n-tricosane() and Tritriacontane n-tricosane(N-trtriaconetane) it is
The normal alkane of main 15-33 carbon atom of tool;Has the long-chain alcohol of 18-31 carbon atom;Cholesterine(), cholesterol rape oil
Sterol(Campesterol), stigmasterol(Stigmasterol), sitosterol() and stearic acid sitosterol(steraric
Acid), palmitic acid(Palmitic acid), oleic acid(oleic acid)[10].
Cortex acanthopanacis:Pharmacological property:Acrid flavour;It is bitter;Micro-sweet;It is warm-natured;Channel tropism:Return liver;Kidney channel;Effect:Wind-damp dispelling;Filling liver kidney;Strengthening tendons
Bone;Promoting blood circulation arteries and veins;It cures mainly:Wind-cold-dampness arthralgia;Lumbocrural pain;Muscles and bones impotence;It is physically weak frail;Traumatic injury;Fracture;Oedema;Tinea pedis;It is cloudy
Under wet itch;Usage and dosage:It is for oral administration:Decoction, 6-9g, fresh goods double;Infusing drugs in wine enters ball, dissipates.External application:In right amount, it decocts as a steam-wash or is
End is applied.Chemical composition of Chinese materia medica:Acanthopanax gracilistylus root skin contains Syringin(Syringin), eleutheroside(Eleutheroside) B1, i.e.,
It is different Chun Piding-alpha-D-glucose glucoside(Isofraxidin- α-D-glucoside), dextrorotation sesamin(Sesamin), 16 α-hydroxyl
Base-()-shell pine -19- acid [16 α-hydroxy- (-)-kauran-19-oic acid) [2], cupreol(β-
Sitosterol), cupreol glycoside(β-sitosterol glucoside), stearic acid(stearc acid)[1]
[1], palmitic acid(Palmitic acid), leukotrienes(Linolenic acid) and vitamin A, B1 etc. [3].Also comprising volatilization
Stain inside has 4-Methyl Salicylaldehyde(4-methyl salicylaldehyde) etc. ingredients [3].Panax sessiliflorus root and root skin are containing left-handed
Sesamin, left-handed Savinin(Savinin) [4], also containing acanthoside(Acanthoside) A, B, C, D, K2, K3 [5-7],
Wherein the structure of glucoside A and glucoside C are unclear, and glucoside B and glucoside D are syringaresinol respectively(Syrinaresinol single glucose)
Glucoside and double glycosides, they belong to lignan class, and glucoside K2 and glucoside K3 then belong to triterpenes.Again containing cupreol, carrot
Glucoside(Daucosterin (it is cupreol glycoside, stigmasterol(Stig-masterol), Lay oil sterol
(Campesterol) [7,8], depth of water polysaccharide and alkaline polysaccharide [9], cardiac glycoside and trace volatile oil.
Radix Rehmanniae:The sweet, slight bitter of property, it is cool.Enter the heart, liver and kidney channel, major function, nourishing Yin and clearing heat, cooling blood and hemostasis;Control warm disease heating,
Tongue is deep red, ecchymosis, and yin asthenia generating intrinsic heat is quenched one's thirst, and is had a dizzy spell, overstrain cough, dry, the soreness of waist, spits blood, bleeding from five sense organs or subcutaneous tissue, hematuria, uterine bleeding, irregular menstruation,
Deficiency of blood intestinal dryness, arthralgia pain due to rheumatism;Chemical composition:Glutinous rehmannia contains a variety of glycosides, mainly iridoid and its glycoside;Ajugol,
Xanthosine, Catalpol(Catalpol), carbohydrate and amino acid;Also contain rehmanin(Rehmannin), alkaloid etc..
Several model cases are lifted below:
Case one:Sun certain, female, 37 years old.Because of " year more than whole skin wheal companion's itch 1O repeatedly ".Once it was diagnosed as by multiple hospitals
" chronic urticaria ".Once sb.'s illness took a favorable turn from after taking Loratadine treatment during breaking-out, but deactivates the state of an illness after medicine is treated and return.
Symptoms include double lower limb skin is dispersed in many places red wheal, no fixed shape has many places cutaneous pigmentation.Itch unbearably, receive can, sleep
Difference, two just adjust.Tongue nature is light red, and tongue is thin white, deeptensepulse.After take ground bone slender acanthopanax dissipate, three times per day, one time one wrap 120 grams, boiling water bubble
It takes or is decocted in water for oral dose, and advise that patient fasts are pungent, fish raw meat food.Continuously take ten days.The cards such as itch are fully recovered, and only lose pigmentation.
It subsequently takes more than February, follow-up is not recurred for 3 years.
Case two, flood certain, man, 39 years old.There are more than ten years of wheal recurrent exerbation in whole body.Occurs wheal before Yu Shinian, every year
It breaks out more than number scholar time, when medication stops, and is discontinued and sends out soon.Multiple hospitals are diagnosed as " chronic urticaria ".Breaking-out is frequent in recent years,
Monthly for several times, vomiting, abdominal pain, diarrhea with loose stool during hair.Private prosecution has duodenal ulcer disease, so far poor appetite.It checks:Whole body can
See and be dispersed in wheal, color is thin.Arteries and veins delays cunning, pale tongue, and tongue is thin white.Doctor trained in Western medicine diagnoses:Chronic urticaria(Stomach type).Now take ground bone five
Add and dissipate for oral administration, three times per day, wrap 120 grams one time one, boiling water is taken after being infused in hot water or decoction or is decocted in water for oral dose, and advises that patient fasts are pungent, fish raw meat food.Even
It is continuous to take 15 days.The diseases such as itch are fully recovered, and subsequently take 30 days, follow-up is not recurred for 3 years.
Specific embodiment:
To combine example, the present invention will be further described, but the invention is not limited in specific embodiment, and a kind of pure Chinese medicine is controlled
The ground bone slender acanthopanax for treating nettle rash dissipates and preparation method, reaches more preferable curative effect, in parts by weight and compatibility, by following Chinese medicine original
Material is prepared, which is characterized in that step is as follows:20 parts of the root bark of Chinese wolf-berry, 35 parts of cortex acanthopanacis, 25 parts of dittany bark, 15 parts of dry Radix Rehmanniae, unpeeled CORTEX MOUTAN
10 parts, red 35 parts of Siberian cocklebur skin, white 25 parts of Siberian cocklebur skin, 20 parts of waxgourd peel, 25 parts of hyacinth bean skin.
A kind of ground bone slender acanthopanax of pure Chinese medicine treatment nettle rash dissipates and preparation method, reaches more preferable curative effect, according to parts by weight
Meter and compatibility, are prepared by following Chinese medicine material, are characterized in that, step is as follows:5 parts of the root bark of Chinese wolf-berry, 5 parts of cortex acanthopanacis, 5 parts of dittany bark,
8 parts of dry Radix Rehmanniae, 3 parts of unpeeled CORTEX MOUTAN, red 5 parts of Siberian cocklebur skin, white 5 parts of Siberian cocklebur skin, 5 parts of waxgourd peel, 5 parts of hyacinth bean skin.
Above to the specific descriptions of the present invention, it is intended to illustrate the realization method of specific embodiment, it is impossible to be not understood as pair
The limitation of the present invention, this field branch art personnel make various under the inspiration of the present invention on the basis of the embodiment of detailed description
Variant, retouching, with dosage form, accommodation, these variants, retouching, with dosage form, accommodation(Such as various pills, tablet, suppository, injection)
It should be included within the design of the present invention.The range of the protection shown of the invention is limited by described claims.
Claims (4)
1. a kind of ground bone slender acanthopanax of the pure Chinese medicine treatment nettle rash dissipates and preparation method, in parts by weight and compatibility, by
Following Chinese medicine material is prepared, which is characterized in that step is as follows:10-20 parts of the root bark of Chinese wolf-berry, 15-35 parts of cortex acanthopanacis, dittany bark 15-
25 parts, 10-15 parts of dry Radix Rehmanniae, 5-10 parts of unpeeled CORTEX MOUTAN, 15-35 parts of fuling peel, white 15-25 parts of Siberian cocklebur skin, waxgourd peel 15-20
Part, 15-25 parts of hyacinth bean skin.
2. a kind of ground bone slender acanthopanax of pure Chinese medicine treatment nettle rash dissipates and preparation method according to claim 1, according to parts by weight
Number meter and compatibility, are prepared, which is characterized in that step is as follows by following Chinese medicine material:20 parts of the root bark of Chinese wolf-berry, 35 parts of cortex acanthopanacis, dittany
25 parts of skin, 15 parts of dry Radix Rehmanniae, 10 parts of unpeeled CORTEX MOUTAN, red 35 parts of Siberian cocklebur skin, white 25 parts of Siberian cocklebur skin, 20 parts of waxgourd peel, 25 parts of hyacinth bean skin.
3. a kind of ground bone slender acanthopanax of pure Chinese medicine treatment nettle rash according to claim 1 dissipates and preparation method, according to weight
Number meter and compatibility are prepared by following Chinese medicine material, are characterized in that, step is as follows:5 parts of the root bark of Chinese wolf-berry, 5 parts of cortex acanthopanacis, dittany bark 5
Part, 8 parts of dry Radix Rehmanniae, 3 parts of unpeeled CORTEX MOUTAN, red 5 parts of Siberian cocklebur skin, white 5 parts of Siberian cocklebur skin, 5 parts of waxgourd peel, 5 parts of hyacinth bean skin.
4. by the good spare spice of more than frying, backup is weighed, crushing and processing are stirred evenly, filtering 200 mesh packing into smalls,
Often packet is packed as 120 grams, and encapsulation is spare;Usage and dosage:Three times per day, one time one packet(120 grams), boiling water is taken after being infused in hot water or decoction or is decocted in water for oral dose,
15 days as one therapeutic course;Accommodation;A variety of anxious, slow nettle rash, anaphylaxis dermatosis, oedema dermatoses, constipation etc..
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810099879.8A CN108186799A (en) | 2018-02-01 | 2018-02-01 | Ground bone slender acanthopanax dissipates and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810099879.8A CN108186799A (en) | 2018-02-01 | 2018-02-01 | Ground bone slender acanthopanax dissipates and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108186799A true CN108186799A (en) | 2018-06-22 |
Family
ID=62592210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810099879.8A Pending CN108186799A (en) | 2018-02-01 | 2018-02-01 | Ground bone slender acanthopanax dissipates and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108186799A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394959A (en) * | 2018-12-17 | 2019-03-01 | 温州古木生物科技有限公司 | It is a kind of to have effects that repair the Chinese medicine composition of keratoderma and its water extract and fermentation material and application |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846830A (en) * | 2012-10-08 | 2013-01-02 | 杨洪义 | Combination medicine used for treating urticaria, as well as preparation method and application thereof |
-
2018
- 2018-02-01 CN CN201810099879.8A patent/CN108186799A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846830A (en) * | 2012-10-08 | 2013-01-02 | 杨洪义 | Combination medicine used for treating urticaria, as well as preparation method and application thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394959A (en) * | 2018-12-17 | 2019-03-01 | 温州古木生物科技有限公司 | It is a kind of to have effects that repair the Chinese medicine composition of keratoderma and its water extract and fermentation material and application |
CN109394959B (en) * | 2018-12-17 | 2021-05-14 | 温州古木生物科技有限公司 | Traditional Chinese medicine composition with skin cuticle repairing effect, aqueous extract and fermentation product of traditional Chinese medicine composition and application of traditional Chinese medicine composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN101797326A (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
CN103041208B (en) | Chinese herbal preparation for treating climacteric syndrome of women, and preparation method thereof | |
CN103301413A (en) | Traditional Chinese medicine composition for treating hyperlipemia and hyperglycemia | |
CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
CN104306659A (en) | Traditional Chinese medicine composition for treating type 2 diabetes | |
CN104815037A (en) | Drug for treating rheumatism accumulated toxin type chronic eczema and preparation method of drug | |
KR101600751B1 (en) | Method of preparing oriental medicine composition containing extract of deer antlers for treating infertility in women | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN108186799A (en) | Ground bone slender acanthopanax dissipates and preparation method | |
KR100514132B1 (en) | Composition and kit for losing body weight | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN108403919B (en) | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and preparation method and application thereof | |
CN107441460A (en) | The Chinese medicinal formulae that a kind of yang-deficiency constitution crowd being used for using chilly as primary symptom nurses one's health | |
CN104474103A (en) | Natural plant hypoglycemic agent and preparation method thereof | |
CN108159378A (en) | Mulberry leather belly skin dissipates and preparation method | |
CN104606570A (en) | Consumptive thirst tea substitute drink suitable for diabetes patients and preparation method of consumptive thirst tea substitute drink | |
CN104825892B (en) | A kind of Chinese medicine preparation for treating ovulation bleeding and preparation method thereof | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN108187004A (en) | A kind of more skins of Chinese medicine treatment nettle rash dissipate and preparation method | |
CN103099886A (en) | Soft capsule helpful for improving intestinal and gastric functions and preparation method thereof | |
CN107029060A (en) | Treat Yao medicinal composition of apoplexy and preparation method thereof | |
CN105288166A (en) | Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180622 |
|
WD01 | Invention patent application deemed withdrawn after publication |